About Antegenes

Antegenes is an innovative biotech and healthcare company specializing in advanced genetic diagnostics. The firm develops and deploys precision genetic tests that assess an individual’s personal risk for various cancers, enabling early detection and personalized prevention strategies. By integrating genetics with clinical decision-making, Antegenes supports healthcare providers in offering proactive, individualized care. The company was founded in 2018 in Estonia by Dr. Peeter Padrik, a medical oncologist and researcher, with the mission to revolutionize cancer prevention through genomics and data-driven healthcare solutions.